The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUBX.L Regulatory News (SUBX)

  • There is currently no data for SUBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results for quarter & half year ended Sep 30, 2019

11 Nov 2019 10:17

RNS Number : 9624S
Subex Limited
11 November 2019
 

 

November 11, 2019

 

To

The London Stock Exchange

10 Paternoster Square

London

EC4M 7LS

 

Dear Sir/Madam,

 

Sub: Outcome of the Board Meeting of Subex Limited "The Company" held on November 08, 2019

 

Please be informed that the agenda item summarized hereunder was discussed and approved at the Board Meeting of the Company held on November 08, 2019 at Bengaluru:

 

·; Unaudited consolidated financial results of the Company for the quarter and half-year ended September 30, 2019.

 

Please find enclosed:

 

·; The unaudited consolidated financial results of the Company for the quarter and half-year ended September 30, 2019.

 

 

We request you to take the aforesaid notification on record.

 

Thanking you

 

Yours truly,

For Subex Limited

 

 

 

Anil Singhvi

Chairman & Independent Director

DIN:00239589

 

 

 

 

 

 

 

SUBEX LIMITED

Registered office: RMZ Ecoworld, Outer Ring Road, Devarabisanahalli, Bangalore - 560 103

Statement of Unaudited Consolidated Financial Results for the quarter and six months ended September 30, 2019

( ` in Lakhs)

Particulars

Quarter ended

Year to date figures for the six months ended

Year ended

September 30, 2019

June 30, 2019

September 30, 2018

September 30, 2019

September 30, 2018

March 31, 2019

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Audited

Income

1

Revenue from operations

8,567

7,895

8,806

16,462

16,397

34,812

2

Other income

140

36

17

176

34

101

3

Total income (1+2)

8,707

7,931

8,823

16,638

16,431

34,913

4

Expenses

(a)

Employee benefits expense (Refer note 4)

4,437

4,309

4,853

8,746

9,358

19,105

(b)

Finance costs

142

150

46

292

108

216

(c)

Depreciation and amortisation expense

378

371

122

749

229

483

(d)

Exchange fluctuation (gain)/ loss, net

(292)

(259)

(283)

(551)

(811)

(171)

(e)

Other expenses

2,331

2,068

2,717

4,399

5,355

10,572

Total expenses

6,996

6,639

7,455

13,635

14,239

30,205

5

Net profit before tax expense (3-4)

1,711

1,292

1,368

3,003

2,192

4,708

6

Tax expense, net

Current tax charge

1

1

38

2

108

274

Provision - foreign withholding taxes (Refer note 6)

263

223

208

486

418

885

Deferred tax charge (Refer note 7)

817

540

491

1,357

640

1,027

Total tax expense

1,081

764

737

1,845

1,166

2,186

7

Net profit for the period/ year (5-6)

630

528

631

1,158

1,026

2,522

8

Other comprehensive income, net of tax expense

Items that will be reclassified subsequently to profit or loss:

Net exchange differences (loss)/ gain on translation of foreign operations

(124)

(266)

295

(390)

(210)

(390)

Items that will not be reclassified subsequently to profit or loss:

Re-measurement loss on defined benefits plan

(25)

(10)

(14)

(35)

(29)

(38)

Total other comprehensive income

(149)

(276)

281

(425)

(239)

(428)

9

Total comprehensive income for the period/ year (7+8)

481

252

912

733

787

2,094

10

Paid up equity share capital

56,200

56,200

56,200

56,200

56,200

56,200

[face value of `10 (March 31, 2019: `10)]

11

Other equity

-

-

-

-

-

23,210

12

Earnings per share (of ` 10/- each) (not annualised in case of the interim periods)

(a)

- Basic

0.12

0.10

0.11

0.21

0.18

0.45

(b)

- Diluted

0.12

0.10

0.11

0.21

0.18

0.45

 

SUBEX LIMITED

Registered office: RMZ Ecoworld, Outer Ring Road, Devarabisanahalli, Bangalore - 560 103

Statement of Consolidated Assets and Liabilities

( ` in Lakhs)

As at

Particulars

September 30, 2019

March 31, 2019

Unaudited

Audited

A

ASSETS

Non-current assets

Property, plant and equipment

543

540

Right-of-use assets

4,489

-

Goodwill on consolidation

65,882

65,882

Other intangible assets

Financial assets

4

7

Loans

530

503

Other balances with banks

419

420

Other financial assets

234

234

Income tax asset (net)

3,081

3,039

Deferred tax asset (including MAT credit entitlement)

642

624

Other non-current assets

267

478

76,091

71,727

Current assets

Financial assets

Loans

133

121

Trade receivables

8,668

8,539

Cash and cash equivalents

6,106

3,947

Other balances with banks

125

252

Other financial assets

3,790

4,537

Other current assets

680

526

19,502

17,922

Total Assets

95,593

89,649

B

EQUITY AND LIABILITIES

Equity

Equity share capital

56,200

56,200

Other equity

23,170

23,210

Total equity

79,370

79,410

Liabilities

Non-current liabilities

Financial liabilities

Lease Liability

3,531

-

Provisions

337

305

Deferred tax liabilities(net)

3,244

1,928

7,112

2,233

Current liabilities

Financial liabilities

Lease Liabilities

Trade payable

1,299

-

- total outstanding dues of micro enterprises and small enterprises

28

7

- total outstanding dues of creditors other than micro enterprises and small enterprises

796

827

Other financial liabilities

2,174

2,961

Other current liabilities

3,168

2,452

Provisions

804

729

Income tax liabilities (net)

842

1,030

9,111

8,006

Total liabilities

16,223

10,239

Total equity and liabilities

95,593

89,649

 

SUBEX LIMITED

Statement of cash flows for the six months ended September 30, 2019

( ` in Lakhs)

Six months ended

Particulars

September 30, 2019

September 30, 2018

Unaudited

Unaudited

(A)

Operating activities

Profit before tax expense

Adjustments to reconcile profit before tax expense to net cash flows:

3,003

2,192

Depreciation of property, plant and equipment and right-of-use assets

746

151

Amortization of intangible assets

3

78

Interest income (including fair value changes)

(64)

(28)

Finance costs (including fair value changes)

243

108

Provision for doubtful debts and advances (net of reversal)

16

338

Expense on share based payment

Amortized cost of deposits

48

29

Net foreign exchange differences

(520)

(445)

Operating profit before working capital changes

3,475

2,423

Working capital adjustments:

(Increase)/ decrease in loans

(7)

(37)

(Increase)/ decrease in trade receivables

89

(1,484)

(Increase)/ decrease in other financial assets

586

(84)

(Increase)/ decrease in other assets

(219)

(88)

Increase/ (decrease) in trade payables

(1)

432

Increase/ (decrease) in other financial liabilities

(697)

(383)

Increase/ (decrease) in other current liabilities

645

598

Increase/ (decrease) in provisions

62

151

3,933

1,528

Income tax paid (including TDS, net of refund)

(710)

(425)

Net cash flows from operating activities

3,223

1,103

(B)

Investing activities

Purchase of property, plant and equipment

(288)

(194)

Movement in margin money deposit (net)

131

(18)

Purchase of treasury shares by ESOP trust

(378)

(32)

Interest received

25

5

Net cash flows used in investing activities

(510)

(239)

(C)

Financing activities

Repayment in working capital loans (net)

(1,027)

Interest paid

(230)

(95)

Repayment of lease liability

(425)

-

Net cash flows used in financing activities

(655)

(1,122)

(D)

Net increase/ (decrease) in cash and cash equivalents (A+B+C)

2,058

(258)

Net foreign exchange difference on cash and cash equivalents

101

(103)

Cash and cash equivalents at the beginning of the period

3,947

3,007

(E)

Cash and cash equivalents at the end of the period

6,106

2,646

 

 

 

Notes:

1 The above results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on November 8, 2019.

2 The financial results have been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards ("Ind AS") prescribed under section 133 of the Companies Act, 2013, read with relevant rules thereunder and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

3 The financial results of Subex Limited (Standalone information):

Particulars

Quarter ended

Year to date figures for the six months ended

Year ended

September 30, 2019

June 30, 2019

September 30, 2018

September 30, 2019

September 30, 2018

March 31, 2019

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Audited

Total income

331

229

481

442

1,128

1,926

Net loss before tax expense

(262)

(512)

(533)

(774)

(1,506)

(2,455)

Net loss for the period/ year

(262)

(512)

(534)

(774)

(1,507)

(2,453)

Total comprehensive income for the period/ year

(263)

(513)

(538)

(776)

(1512)

(2,456)

( `in Lakhs)

4 Employee benefits expenses for the quarters ended September 30, 2019, June 30, 2019, and September 30, 2018 are net of reversal of provision no longer required, in respect of employee incentives relating to sales and delivery commissions, amounting to ` 438 Lakhs, ` 450 Lakhs and ` 35 Lakhs, respectively, that for the six months ended September 30, 2019 and September 30, 2018 amounting to ` 888 Lakhs and ` 35 Lakhs and that for the year ended March 31, 2019 amounting to ` 40 Lakhs.

5 As at March 31, 2019, the Group assessed and concluded the carrying value of it's goodwill along with carrying value of related Cash Generating Units ('CGUs') to be appropriate, basis the valuation carried out by an external valuer. There is no change in the management's assessment as regards the aforementioned carrying value of it's goodwill along with carrying value of related CGU as at September 30, 2019.

6 Represents provision in respect of withholding taxes deducted/ deductible by the overseas customers of the Group.

7 Deferred tax charge/ (credit), comprises of deferred tax liability arising on account of tax benefits from amortisation of intangible assets of Subex Assurance LLP, net of deferred tax assets arising on account of carry forward losses and other taxable temporary differences, which arose mainly on account of business restructuring effected from November 1, 2017, wherein, the Company's RMS business and the Digital business was transferred on going concern basis to Subex Assurance LLP and Subex Digital LLP respectively.

8 The Group is engaged in the business of software products and related services, which are monitored as a single segment by the Chief Operating Decision Maker, accordingly, these, in the context of Ind AS 108 on Operating Segments Reporting are considered to constitute one segment and hence the Group has not made any additional segment disclosures.

9 Subex Employee Welfare and ESOP Benefit Trust (hereinafter referred to as the "ESOP Trust"), registered and authorised to acquire shares of the Company through secondary market for providing share-based payments to its employees, is consolidated in the standalone financial results of the Company and the shares reacquired and held by ESOP Trust are treated as treasury shares and recognised at cost and deducted from other equity. The shares held by the Trust were reduced on a weighted average basis from outstanding number of shares for computation of basic and diluted EPS of the Company.

Effective April 1, 2019, the Group adopted Ind AS 116 "Leases", applied to all lease contracts existing on April 1, 2019 using the modified retrospective method and has taken the cumulative adjustment to retained earnings, on the date of initial application. Accordingly, comparatives for the year ended March 31, 2019 have not been retrospectively adjusted. On transition, the adoption of the new standard resulted in recognition of Right-of-Use asset (ROU) of `4,816 Lakhs and a lease liability of `5,052 Lakhs. The cumulative effect of applying the standard resulted in `442 Lakhs being debited to retained earnings, net of taxes.

Place: Bengaluru

Date: November 8, 2019

Vinod Kumar Padmanabhan Managing Director & CEO

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMFFEFSFFUSEFF
Date   Source Headline
9th Aug 202210:35 amRNSOutcome of the Board Meeting held on August 8,2022
30th Jun 20223:42 pmRNSProposed termination of GDRs & De-listing
1st Jun 202211:52 amRNSOutcome of Board Meeting dated May 30, 2022
1st Feb 202211:11 amRNSOutcome of Board Meeting held on Jan 31, 2022
29th Oct 20218:37 amRNSOutcome of Board Meeting held on October 28, 2021
10th Aug 202111:41 amRNSOutcome of the Board Meeting on August 09, 2021
15th Jun 202111:56 amRNSNotice of Twenty Seventh Annual General Meeting
18th May 202111:20 amRNSOutcome of the Board Meeting held on May 17, 2021
2nd Feb 202112:38 pmRNSOutcome of the Board Meeting February 01,2021
10th Nov 202011:32 amRNSOutcome of the Board Meeting November 09,2020
1st Sep 202012:01 pmRNSNotice of the Twenty Sixth Annual General Meeting
11th Aug 20202:34 pmRNSOutcome of Board Meeting on August 10, 2020
12th May 20207:31 amRNSSubex Limited-Outcome of Board Meeting 11 May 2020
12th Feb 20207:00 amRNSOutcome of the Board Meeting of Subex Limited
11th Nov 201910:17 amRNSResults for quarter & half year ended Sep 30, 2019
13th Aug 201911:02 amRNSOutcome of the Board Meeting - August 12, 2019
10th Jun 201911:55 amRNSNotice of the Twenty Fifth Annual General Meeting
14th May 20199:51 amRNSSubex Limited Outcome -Board Meeting -May 13, 2019
30th Jan 20197:00 amRNSOutcome of the Board Meeting held on Jan 29, 2019
2nd Nov 20187:08 amRNSOutcome of the Board Meeting- October 31, 2018
1st Aug 20187:00 amRNS1st Quarter Results
12th Jul 20187:26 amRNSThe Twenty Fourth AGM of Subex Limited
27th Jun 20187:38 amRNSSubex Limited-Outcome -Board Meeting June 26,2018
4th May 20183:00 pmRNSFinal Results
22nd Mar 201811:29 amRNSAppointment of MD & CEO of Subex Ltd
30th Jan 20189:50 amRNSFinancial Results - 3rd Quarter
13th Nov 201710:01 amRNSOutcome of Board Meeting held on November 10 2017
2nd Nov 201711:54 amRNSRestructuring of the Business wef Nov 1, 2017
5th Oct 20177:00 amRNSOutcome of Board Meeting held on October 4, 2017
22nd Aug 201711:47 amRNSOutcome of Board Meeting held on August 21, 2017
31st Jul 201711:38 amRNS1st Quarter Results
10th Jul 201711:40 amRNSRedemption of FCCB III
4th Jul 201711:05 amRNSNotice of AGM
5th Jun 201711:25 amRNSOutcome of the Board Meeting held on June 05, 2017
5th Jun 201711:15 amRNSOutcome of the Board Meeting held on June 05, 2017
26th May 20177:00 amRNSFinal Results
24th Mar 201711:41 amRNSOutcome of the Board Meeting held on March 24 2017
7th Mar 20178:26 amRNSIntimation on Redemption of FCCBs
3rd Feb 201710:46 amRNSSubex Limited 3rd Quarter Results
7th Dec 20167:50 amRNSOutcome of Board Meeting held on December 06 2016
14th Sep 20167:47 amRNS1st Quarter Results
22nd Aug 201611:14 amRNSNotice of AGM
10th Aug 201610:43 amRNSOutcome of the Board Meeting- August 9, 2016
25th May 201610:51 amRNSSubex Limited-Outcome of Board Meeting
11th Feb 201612:18 pmRNS3rd Quarter Results
3rd Nov 20152:44 pmRNSResult of Meeting
27th Aug 20158:45 amRNSSubex Limited (The Company)-Update
13th Aug 20152:00 pmRNS1st Quarter Results
3rd Jul 201511:55 amRNSNotice of the Outcome of Bondholders meeting
27th May 201512:44 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.